<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37450246</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-1182</ISSN><JournalIssue CitedMedium="Internet"><Volume>60</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Molecular neurobiology</Title><ISOAbbreviation>Mol Neurobiol</ISOAbbreviation></Journal><ArticleTitle>Different Chronic Stress Paradigms Converge on Endogenous TDP43 Cleavage and Aggregation.</ArticleTitle><Pagination><StartPage>6346</StartPage><EndPage>6361</EndPage><MedlinePgn>6346-6361</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12035-023-03455-z</ELocationID><Abstract><AbstractText>The TAR-DNA binding protein (TDP43) is a nuclear protein whose cytoplasmic inclusions are hallmarks of Amyotrophic Lateral Sclerosis (ALS). Acute stress in cells causes TDP43 mobilization to the cytoplasm and its aggregation through different routes. Although acute stress elicits a strong phenotype, is far from recapitulating the years-long aggregation process. We applied different chronic stress protocols and described TDP43 aggregation in a human neuroblastoma cell line by combining solubility assays, thioflavin-based microscopy and flow cytometry. This approach allowed us to detect, for the first time to our knowledge in vitro, the formation of 25&#xa0;kDa C-terminal fragment of TDP43, a pathogenic hallmark of ALS. Our results indicate that chronic stress, compared to the more common acute stress paradigm, better recapitulates the cell biology of TDP43 proteinopathies. Moreover, we optimized a protocol for the detection of bona fide prions in living cells, suggesting that TDP43 may form amyloids as a stress response.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Candelise</LastName><ForeName>Niccol&#xf2;</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Experimental Medicine, University La Sapienza, 00185, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS Fondazione Santa Lucia, 00179, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caissutti</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Experimental Medicine, University La Sapienza, 00185, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zenuni</LastName><ForeName>Henri</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Systems Medicine, Tor Vergata" University of Rome, 00133, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nesci</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>IRCCS Fondazione Santa Lucia, 00179, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Systems Medicine, Tor Vergata" University of Rome, 00133, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scaricamazza</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>IRCCS Fondazione Santa Lucia, 00179, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salvatori</LastName><ForeName>Illari</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Experimental Medicine, University La Sapienza, 00185, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS Fondazione Santa Lucia, 00179, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spinello</LastName><ForeName>Zaira</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Experimental Medicine, University La Sapienza, 00185, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mattei</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Biomedicine and Advanced Technologies Rieti Center, Sabina Universitas, 02100, Rieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garofalo</LastName><ForeName>Tina</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Experimental Medicine, University La Sapienza, 00185, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferri</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>IRCCS Fondazione Santa Lucia, 00179, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Translational Pharmacology (IFT), Consiglio Nazionale Delle Ricerche (CNR), 00185, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valle</LastName><ForeName>Cristiana</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>IRCCS Fondazione Santa Lucia, 00179, Rome, Italy. cristiana.valle@cnr.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Translational Pharmacology (IFT), Consiglio Nazionale Delle Ricerche (CNR), 00185, Rome, Italy. cristiana.valle@cnr.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Misasi</LastName><ForeName>Roberta</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-1181-6190</Identifier><AffiliationInfo><Affiliation>Department of Experimental Medicine, University La Sapienza, 00185, Rome, Italy. roberta.misasi@uniroma1.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Post-doctoral Fellowship 2021 - anno 2021</GrantID><Agency>Fondazione Umberto Veronesi</Agency><Country/></Grant><Grant><GrantID>CUP B89J22001910007</GrantID><Agency>Fondazione Cassa di Risparmio di Pistoia e Pescia</Agency><Country/></Grant><Grant><GrantID>PRIN 20109MXHNR</GrantID><Agency>Ministero dell'Universit&#xe0; e della Ricerca</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Neurobiol</MedlineTA><NlmUniqueID>8900963</NlmUniqueID><ISSNLinking>0893-7648</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003593" MajorTopicYN="N">Cytoplasm</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="Y">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009447" MajorTopicYN="N">Neuroblastoma</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057177" MajorTopicYN="N">TDP-43 Proteinopathies</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic Lateral Sclerosis</Keyword><Keyword MajorTopicYN="N">Chronic stress</Keyword><Keyword MajorTopicYN="N">Prion</Keyword><Keyword MajorTopicYN="N">TDP43</Keyword><Keyword MajorTopicYN="N">Thioflavin</Keyword></KeywordList><CoiStatement>The authors have no relevant financial or non-financial interests to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>14</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>14</Day><Hour>11</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37450246</ArticleId><ArticleId IdType="pmc">PMC10533643</ArticleId><ArticleId IdType="doi">10.1007/s12035-023-03455-z</ArticleId><ArticleId IdType="pii">10.1007/s12035-023-03455-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kawakami I, Arai T, Hasegawa M. The basis of clinicopathological heterogeneity in TDP-43 proteinopathy. Acta Neuropathol. 2019;138(5):751&#x2013;770. doi: 10.1007/s00401-019-02077-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02077-x</ArticleId><ArticleId IdType="pmc">PMC6800885</ArticleId><ArticleId IdType="pubmed">31555895</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ, Kwong LK, Forman MS, et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol. 2007;61(5):427&#x2013;434. doi: 10.1002/ana.21147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21147</ArticleId><ArticleId IdType="pubmed">17469116</ArticleId></ArticleIdList></Reference><Reference><Citation>de Boer EMJ, Orie VK, Williams T, Baker MR, De Oliveira HM, Polvikoski T, Silsby M, Menon P, et al. TDP-43 proteinopathies: a new wave of neurodegenerative diseases. J Neurol Neurosurg Psychiatry. 2020;92(1):86&#x2013;95. doi: 10.1136/jnnp-2020-322983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-322983</ArticleId><ArticleId IdType="pmc">PMC7803890</ArticleId><ArticleId IdType="pubmed">33177049</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson JL, Geser F, Stieber A, Umoh M, Kwong LK, Van Deerlin VM, Lee VM, Trojanowski JQ. TDP-43 skeins show properties of amyloid in a subset of ALS cases. Acta Neuropathol. 2013;125(1):121&#x2013;131. doi: 10.1007/s00401-012-1055-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1055-8</ArticleId><ArticleId IdType="pmc">PMC3536927</ArticleId><ArticleId IdType="pubmed">23124365</ArticleId></ArticleIdList></Reference><Reference><Citation>Suk TR, Rousseaux MWC. The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. Mol Neurodegener. 2020;15(1):45. doi: 10.1186/s13024-020-00397-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00397-1</ArticleId><ArticleId IdType="pmc">PMC7429473</ArticleId><ArticleId IdType="pubmed">32799899</ArticleId></ArticleIdList></Reference><Reference><Citation>Giordana MT, Piccinini M, Grifoni S, De Marco G, Vercellino M, Magistrello M, Pellerino A, Buccinn&#xe0; B, et al. TDP-43 redistribution is an early event in sporadic amyotrophic lateral sclerosis. Brain Pathol. 2010;20(2):351&#x2013;360. doi: 10.1111/j.1750-3639.2009.00284.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-3639.2009.00284.x</ArticleId><ArticleId IdType="pmc">PMC8094784</ArticleId><ArticleId IdType="pubmed">19338576</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvatori I, Ferri A, Scaricamazza S, Giovannelli I, Serrano A, Rossi S, D'Ambrosi N, Cozzolino M, et al. Differential toxicity of TAR DNA-binding protein 43 isoforms depends on their submitochondrial localization in neuronal cells. J Neurochem. 2018;146(5):585&#x2013;597. doi: 10.1111/jnc.14465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14465</ArticleId><ArticleId IdType="pubmed">29779213</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozzo F, Salvatori I, Iacovelli F, Mirra A, Rossi S, Cozzolino M, Falconi M, Valle C, et al. Structural insights into the multi-determinant aggregation of TDP-43 in motor neuron-like cells. Neurobiol Dis. 2016;94:63&#x2013;72. doi: 10.1016/j.nbd.2016.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.06.006</ArticleId><ArticleId IdType="pubmed">27317832</ArticleId></ArticleIdList></Reference><Reference><Citation>Arseni D, Hasegawa M, Murzin AG, Kametani F, Arai M, Yoshida M, Ryskeldi-Falcon B. Structure of pathological TDP-43 filaments from ALS with FTLD. Nature. 2022;601(7891):139&#x2013;143. doi: 10.1038/s41586-021-04199-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04199-3</ArticleId><ArticleId IdType="pmc">PMC7612255</ArticleId><ArticleId IdType="pubmed">34880495</ArticleId></ArticleIdList></Reference><Reference><Citation>Igaz LM, Kwong LK, Chen-Plotkin A, Winton MJ, Unger TL, Xu Y, Neumann M, Trojanowski JQ, et al. Expression of TDP-43 C-terminal Fragments in Vitro Recapitulates Pathological Features of TDP-43 Proteinopathies. J Biol Chem. 2009;284(13):8516&#x2013;8524. doi: 10.1074/jbc.M809462200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M809462200</ArticleId><ArticleId IdType="pmc">PMC2659210</ArticleId><ArticleId IdType="pubmed">19164285</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuji H, Arai T, Kametani F, Nonaka T, Yamashita M, Suzukake M, Hosokawa M, Yoshida M, et al. Molecular analysis and biochemical classification of TDP-43 proteinopathy. Brain. 2012;135(Pt11):3380&#x2013;3391. doi: 10.1093/brain/aws230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws230</ArticleId><ArticleId IdType="pubmed">23035040</ArticleId></ArticleIdList></Reference><Reference><Citation>Chhangani D, Mart&#xed;n-Pe&#xf1;a A, Rincon-Limas DE. Molecular, functional, and pathological aspects of TDP-43 fragmentation. IScience. 2021;24(5):102459. doi: 10.1016/j.isci.2021.102459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.102459</ArticleId><ArticleId IdType="pmc">PMC8113996</ArticleId><ArticleId IdType="pubmed">34013172</ArticleId></ArticleIdList></Reference><Reference><Citation>Feneberg E, Charles PD, Finelli MJ, Scott C, Kessler BM, Fischer R, Ansorge O, Gray E, et al. Detection and quantification of novel C-terminal TDP-43 fragments in ALS-TDP. Brain Pathol. 2021;31(4):e12923. doi: 10.1111/bpa.12923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12923</ArticleId><ArticleId IdType="pmc">PMC8412074</ArticleId><ArticleId IdType="pubmed">33300249</ArticleId></ArticleIdList></Reference><Reference><Citation>Berning BA, Walker AK. The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD. Front Neurosci. 2019;13:335. doi: 10.3389/fnins.2019.00335.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00335</ArticleId><ArticleId IdType="pmc">PMC6470282</ArticleId><ArticleId IdType="pubmed">31031584</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesiridis GS, Lee VMY, Trojanowski JQ. Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis. Hum Mol Genet. 2009;18(R2):R156&#x2013;R162. doi: 10.1093/hmg/ddp303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp303</ArticleId><ArticleId IdType="pmc">PMC2758707</ArticleId><ArticleId IdType="pubmed">19808791</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim G, Gautier O, Tassoni-Tsuchida E, Ma XR, Gitler AD. ALS Genetics: Gains, Losses, and Implications for Future Therapies. Neuron. 2020;108(5):822&#x2013;824. doi: 10.1016/j.neuron.2020.08.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.08.022</ArticleId><ArticleId IdType="pmc">PMC7736125</ArticleId><ArticleId IdType="pubmed">32931756</ArticleId></ArticleIdList></Reference><Reference><Citation>Candelise N, Scaricamazza S, Salvatori I, Ferri A, Valle C, Manganelli V, Garofalo T, Sorice M, et al. Protein Aggregation Landscape in Neurodegenerative Diseases: Clinical Relevance and Future Applications. Int J Mol sci. 2021;22(11):6016. doi: 10.3390/ijms22116016.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22116016</ArticleId><ArticleId IdType="pmc">PMC8199687</ArticleId><ArticleId IdType="pubmed">34199513</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto C, Pritzkow S. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat Neurosci. 2018;21(10):1332&#x2013;1340. doi: 10.1038/s41593-018-0235-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0235-9</ArticleId><ArticleId IdType="pmc">PMC6432913</ArticleId><ArticleId IdType="pubmed">30250260</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathieu C, Pappu RV, Taylor JP. Beyond aggregation: pathological phase transitions in neurodegenerative disease. Science. 2020;370(6512):56&#x2013;60. doi: 10.1126/science.abb8032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb8032</ArticleId><ArticleId IdType="pmc">PMC8359821</ArticleId><ArticleId IdType="pubmed">33004511</ArticleId></ArticleIdList></Reference><Reference><Citation>Blokhuis AM, Groen EJ, Koppers M, van den Berg LH, Pasterkamp RJ. Protein aggregation in Amyotrophic Lateral Sclerosis. Acta Neuropathol. 2013;125(6):777&#x2013;794. doi: 10.1007/s00401-013-1125-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1125-6</ArticleId><ArticleId IdType="pmc">PMC3661910</ArticleId><ArticleId IdType="pubmed">23673820</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YB, Scotter EL, Lee DY, Troakes C, Mitchell J, Rogelj B, Gallo JM, Shaw CE. Cytoplasmic TDP-43 is involved in cell fate during stress recovery. Hum Mol Genet. 2021;31(2):166&#x2013;175. doi: 10.1093/hmg/ddab227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddab227</ArticleId><ArticleId IdType="pmc">PMC8743001</ArticleId><ArticleId IdType="pubmed">34378050</ArticleId></ArticleIdList></Reference><Reference><Citation>Higashi S, Kabuta T, Nagai Y, Tsuchiya Y, Akiyama H, Wada K. TDP-43 associates with stalled ribosomes and contributes to cell survival during cellular stress. J Neurochem. 2013;126(2):288&#x2013;300. doi: 10.1111/jnc.12194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.12194</ArticleId><ArticleId IdType="pubmed">23398327</ArticleId></ArticleIdList></Reference><Reference><Citation>Hans F, Glasebach H, Kahle PJ. Multiple distinct pathways lead to hyperubiquitylated insoluble TDP-43 protein independent of its translocation into stress granules. J Biol Chem. 2020;295(3):673&#x2013;689. doi: 10.1016/S0021-9258(17)49926-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(17)49926-1</ArticleId><ArticleId IdType="pmc">PMC6970928</ArticleId><ArticleId IdType="pubmed">31780563</ArticleId></ArticleIdList></Reference><Reference><Citation>Pillai M, Jha SK. Early Metastable Assembly during the Stress-Induced Formation of Worm-like Amyloid Fibrils of Nucleic Acid Binding Domains of TDP-43. Biochemistry. 2020;59(3):315&#x2013;328. doi: 10.1021/acs.biochem.9b00780.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.biochem.9b00780</ArticleId><ArticleId IdType="pubmed">31898895</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishii T, Kawakami E, Endo K, Misawa H, Watabe K. Formation and spreading of TDP-43 aggregates in cultured neuronal and glial cells demonstrated by time-lapse imaging. PLoS ONE. 2017;12(6):e0179375. doi: 10.1371/journal.pone.0179375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0179375</ArticleId><ArticleId IdType="pmc">PMC5466347</ArticleId><ArticleId IdType="pubmed">28599005</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker SJ, Meyerowitz J, James JL, Liddell JR, Crouch PJ, Kanninen KM, White AR. Endogenous TDP-43 localized to stress granules can subsequently form protein aggregates. Neurochem Int. 2012;60(4):415&#x2013;424. doi: 10.1016/j.neuint.2012.01.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2012.01.019</ArticleId><ArticleId IdType="pubmed">22306778</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T, Masuda-Suzukake M, Arai T, Hasegawa Y, Akatsu H, Obi T, Yoshida M, Murayama S, et al. Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Rep. 2013;4(1):124&#x2013;134. doi: 10.1016/j.celrep.2013.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.06.007</ArticleId><ArticleId IdType="pubmed">23831027</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasset-Rosa F, Lu S, Yu H, Chen C, Melamed Z, Guo L, Shorter J, Da Cruz S, et al. Cytoplasmic TDP-43 De-mixing Independent of Stress Granules Drives Inhibition of Nuclear Import, Loss of Nuclear TDP-43, and Cell Death. Neuron. 2019;102(2):339&#x2013;357. doi: 10.1016/j.neuron.2019.02.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.02.038</ArticleId><ArticleId IdType="pmc">PMC6548321</ArticleId><ArticleId IdType="pubmed">30853299</ArticleId></ArticleIdList></Reference><Reference><Citation>Besnard-Gu&#xe9;rin C. Cytoplasmic localization of amyotrophic lateral sclerosis-related TDP-43 proteins modulates stress granule formation. Eur J Neurosci. 2020;52(8):3995&#x2013;4008. doi: 10.1111/ejn.14762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejn.14762</ArticleId><ArticleId IdType="pubmed">32343854</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A, Gumina V, Lenzi P, Bossolasco P, Fulceri F, Volpe C, Bardelli D, Pregnolato F, et al. Chronic stress induces formation of stress granules and pathological TDP-43 aggregates in human ALS fibroblasts and iPSC-motoneurons. Neurobiol Dis. 2020;145:105051. doi: 10.1016/j.nbd.2020.105051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105051</ArticleId><ArticleId IdType="pubmed">32827688</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh CW, Lee IC, Sundaram JR, George SE, Yusoff P, Brush MH, Sze NSK, Shenolikar S. Chronic oxidative stress promotes GADD34-mediated phosphorylation of the TAR DNA-binding protein TDP-43, a modification linked to neurodegeneration. J Biol Chem. 2018;293(1):163&#x2013;176. doi: 10.1074/jbc.M117.814111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M117.814111</ArticleId><ArticleId IdType="pmc">PMC5766914</ArticleId><ArticleId IdType="pubmed">29109149</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L, Wang HX, Zhu XJ, Wu PH, Chen WQ, Zou P, Li QB, Chen ZC. Serum deprivation elevates the levels of microvesicles with different size distributions and selectively enriched proteins in human myeloma cells in vitro. Acta Pharmacol Sin. 2014;35(3):381&#x2013;393. doi: 10.1038/aps.2013.166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aps.2013.166</ArticleId><ArticleId IdType="pmc">PMC4647891</ArticleId><ArticleId IdType="pubmed">24374813</ArticleId></ArticleIdList></Reference><Reference><Citation>Wisessaowapak C, Visitnonthachai D, Watcharasit P, Satayavivad J. Prolonged arsenic exposure increases tau phosphorylation in differentiated SH-SY5Y cells: The contribution of GSK3 and ERK1/2. Environ Toxicol Pharmacol. 2021;84:103626. doi: 10.1016/j.etap.2021.103626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.etap.2021.103626</ArticleId><ArticleId IdType="pubmed">33621689</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivera-Santa Catalina M, Caballero-Bermejo M, Argent R, Alonso JC, Cuenda A, Lorenzo MJ, Centeno F. Hyperosmotic Stress Induces Tau Proteolysis by Caspase-3 Activation in SH-SY5Y Cells. J Cell Biochem. 2016;117(12):2781&#x2013;2790. doi: 10.1002/jcb.25579.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.25579</ArticleId><ArticleId IdType="pubmed">27152883</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CY, Sivalingam K, Shibu MA, Liao PH, Ho TJ, Kuo WW, Chen RJ, Day CH, et al. Induction of Autophagy by Vasicinone Protects Neural Cells from Mitochondrial Dysfunction and Attenuates Paraquat-Mediated Parkinson's Disease Associated &#x3b1;-Synuclein Levels. Nutrients. 2020;12(6):1707. doi: 10.3390/nu12061707.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12061707</ArticleId><ArticleId IdType="pmc">PMC7352463</ArticleId><ArticleId IdType="pubmed">32517337</ArticleId></ArticleIdList></Reference><Reference><Citation>Mengual G&#xf3;mez DL, Belaich MN, Rodr&#xed;guez VA, Ghiringhelli PD. Effects of Fetal Bovine Serum deprivation in cell cultures on the production of Anticarsia gemmatalis Multinucleopolyhedrovirus. BMC Biotechnol. 2010;10:68. doi: 10.1186/1472-6750-10-68.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6750-10-68</ArticleId><ArticleId IdType="pmc">PMC2949788</ArticleId><ArticleId IdType="pubmed">20843354</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye J, Zhang X, Dong Z. Characterization of the human granulocyte-macrophage colony-stimulating factor gene promoter: an AP1 complex and an Sp1-related complex transactivate the promoter activity that is suppressed by a YY1 complex. Mol Cell Biol. 1996;16(1):157&#x2013;167. doi: 10.1128/MCB.16.1.157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.16.1.157</ArticleId><ArticleId IdType="pmc">PMC230989</ArticleId><ArticleId IdType="pubmed">8524292</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala YM, De Conti L, Avenda&#xf1;o-V&#xe1;zquez SE, Dhir A, Romano M, D'Ambrogio A, Tollervey J, Ule J, et al. TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J. 2011;30(2):277&#x2013;288. doi: 10.1038/emboj.2010.310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2010.310</ArticleId><ArticleId IdType="pmc">PMC3025456</ArticleId><ArticleId IdType="pubmed">21131904</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x10c;esnik AB, Motaln H, Rogelj B. The Impact of ALS-Associated Genes hnRNPA1, MATR3, VCP and UBQLN2 on the Severity of TDP-43 Aggregation. Cells. 2020;9(8):21791.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7465640</ArticleId><ArticleId IdType="pubmed">32731393</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J, Wang L, Huntley ML, Perry G, Wang X. Pathomechanisms of TDP-43 in neurodegeneration. J Neurochem. 2018 doi: 10.1111/jnc.14327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14327</ArticleId><ArticleId IdType="pmc">PMC6110993</ArticleId><ArticleId IdType="pubmed">29486049</ArticleId></ArticleIdList></Reference><Reference><Citation>Meneses A, Koga S, O'Leary J, Dickson DW, Bu G, Zhao N. TDP-43 Pathology in Alzheimer's Disease. Mol Neurodegener. 2021;16(1):84. doi: 10.1186/s13024-021-00503-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-021-00503-x</ArticleId><ArticleId IdType="pmc">PMC8691026</ArticleId><ArticleId IdType="pubmed">34930382</ArticleId></ArticleIdList></Reference><Reference><Citation>Chanson JB, Echaniz-Laguna A, Vogel T, Mohr M, Benoilid A, Kaltenbach G, Kiesmann M. TDP43-positive intraneuronal inclusions in a patient with motor neuron disease and Parkinson's disease. Neurodegener Dis. 2010;7(4):260&#x2013;264. doi: 10.1159/000273591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000273591</ArticleId><ArticleId IdType="pubmed">20197650</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez II, Nguyen TB, England WE, Lim RG, Vu AQ, Miramontes R, Byrne LM, Markmiller S, et al. Huntington's disease mice and human brain tissue exhibit increased G3BP1 granules and TDP43 mislocalization. J Clin Invest. 2021;131(12):e140723. doi: 10.1172/JCI140723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI140723</ArticleId><ArticleId IdType="pmc">PMC8203471</ArticleId><ArticleId IdType="pubmed">33945510</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Kwong LK, Lee EB, Kremmer E, Flatley A, Xu Y, Forman MS, Troost D, et al. Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol. 2009;117(2):137&#x2013;149. doi: 10.1007/s00401-008-0477-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0477-9</ArticleId><ArticleId IdType="pmc">PMC2693625</ArticleId><ArticleId IdType="pubmed">19125255</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y, Beach TG, Buratti E, et al. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol. 2008;64(1):60&#x2013;70. doi: 10.1002/ana.21425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21425</ArticleId><ArticleId IdType="pmc">PMC2674108</ArticleId><ArticleId IdType="pubmed">18546284</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewey CM, Cenik B, Sephton CF, Dries DR, Mayer P, 3rd, Good SK, Johnson BA, Herz J, et al. TDP-43 is directed to stress granules by sorbitol, a novel physiological osmotic and oxidative stressor. Mol Cell Biol. 2011;31(5):1098&#x2013;1108. doi: 10.1128/MCB.01279-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.01279-10</ArticleId><ArticleId IdType="pmc">PMC3067820</ArticleId><ArticleId IdType="pubmed">21173160</ArticleId></ArticleIdList></Reference><Reference><Citation>Wobst HJ, Delsing L, Brandon NJ, Moss SJ. Truncation of the TAR DNA-binding protein 43 is not a prerequisite for cytoplasmic relocalization, and is suppressed by caspase inhibition and by introduction of the A90V sequence variant. PLoS ONE. 2017;12(5):e0177181. doi: 10.1371/journal.pone.0177181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0177181</ArticleId><ArticleId IdType="pmc">PMC5433705</ArticleId><ArticleId IdType="pubmed">28510586</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao C, Gu J, Zhang H, Jiang K, Tang L, Liu R, Zhang L, Zhang P, et al. Hyperosmotic-stress-induced liquid-liquid phase separation of ALS-related proteins in the nucleus. Cell Rep. 2022;40(3):111086. doi: 10.1016/j.celrep.2022.111086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2022.111086</ArticleId><ArticleId IdType="pubmed">35858576</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Duan Y, Duan G, Wang Q, Zhang K, Deng X, Qian B, Gu J, et al. Stress Induces Dynamic, Cytotoxicity-Antagonizing TDP-43 Nuclear Bodies via Paraspeckle LncRNA NEAT1-Mediated Liquid-Liquid Phase Separation. Mol Cell. 2020;79(3):443&#x2013;458. doi: 10.1016/j.molcel.2020.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2020.06.019</ArticleId><ArticleId IdType="pubmed">32649883</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombrita C, Zennaro E, Fallini C, Weber M, Sommacal A, Buratti E, Silani V, Ratti A. TDP-43 is recruited to stress granules in conditions of oxidative insult. J Neurochem. 2009;111(4):1051&#x2013;1061. doi: 10.1111/j.1471-4159.2009.06383.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06383.x</ArticleId><ArticleId IdType="pubmed">19765185</ArticleId></ArticleIdList></Reference><Reference><Citation>Streit L, Kuhn T, Vomhof T, Bopp V, Ludolph AC, Weishaupt JH, Gebhardt JCM, Michaelis J, et al. Stress induced TDP-43 mobility loss independent of stress granules. Naty Commun. 2022;123(1):5480. doi: 10.1038/s41467-022-32939-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32939-0</ArticleId><ArticleId IdType="pmc">PMC9485239</ArticleId><ArticleId IdType="pubmed">36123343</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, Xu YF, Cook C, Gendron TF, Roettges P, Link CD, Lin WL, Tong J, et al. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc Natl Acad Sci USA. 2009;106(18):7607&#x2013;7612. doi: 10.1073/pnas.0900688106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0900688106</ArticleId><ArticleId IdType="pmc">PMC2671323</ArticleId><ArticleId IdType="pubmed">19383787</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Q, Chaplin J, Morris MJ, Hilliard MA, Wolvetang E, Ng DCH, Noakes PG. TDP-43 Mutation Affects Stress Granule Dynamics in Differentiated NSC-34 Motoneuron-Like Cells. Front Cell Dev Biol. 2021;9:611601. doi: 10.3389/fcell.2021.611601.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.611601</ArticleId><ArticleId IdType="pmc">PMC8217991</ArticleId><ArticleId IdType="pubmed">34169068</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyerowitz J, Parker SJ, Vella LJ, Ng DCh, Price KA, Liddell JR, Caragounis A, Li QX, et al. C-Jun N-terminal kinase controls TDP-43 accumulation in stress granules induced by oxidative stress. Mol Neurodegener. 2011;6:57. doi: 10.1186/1750-1326-6-57.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-6-57</ArticleId><ArticleId IdType="pmc">PMC3162576</ArticleId><ArticleId IdType="pubmed">21819629</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei Y, Zhang ZF, Lei RX, Wang S, Zhuang Y, Liu AC, Wu Y, Chen J, et al. DJ-1 Suppresses Cytoplasmic TDP-43 Aggregation in Oxidative Stress-Induced Cell Injury. J Alzheimers Dis. 2018;66(3):1001&#x2013;1014. doi: 10.3233/JAD-180460.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-180460</ArticleId><ArticleId IdType="pubmed">30372676</ArticleId></ArticleIdList></Reference><Reference><Citation>Scial&#xf2; C, Tran TH, Salzano G, Novi G, Caponnetto C, Chi&#xf2; A, Calvo A, Canosa A, et al. TDP-43 real-time quaking induced conversion reaction optimization and detection of seeding activity in CSF of amyotrophic lateral sclerosis and frontotemporal dementia patients. Brain Commun. 2020;2(2):fcaa142. doi: 10.1093/braincomms/fcaa142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa142</ArticleId><ArticleId IdType="pmc">PMC7566418</ArticleId><ArticleId IdType="pubmed">33094285</ArticleId></ArticleIdList></Reference><Reference><Citation>Candelise N, Schmitz M, Da Silva Correia SM, Arora AS, Villar-Piqu&#xe9; A, Zafar S, Llorens F, Cramm M, et al. Applications of the real-time quaking-induced conversion assay in diagnosis, prion strain-typing, drug pre-screening and other amyloidopathies. Expert Rev Mol Diagn. 2017;17(10):897&#x2013;904. doi: 10.1080/14737159.2017.1368389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737159.2017.1368389</ArticleId><ArticleId IdType="pubmed">28817974</ArticleId></ArticleIdList></Reference><Reference><Citation>Cazzaniga FA, De Luca CMG, Bistaffa E, Consonni A, Legname G, Giaccone G, Moda F. Cell-free amplification of prions: Where do we stand? Prog Mol Biol Transl Sci. 2020;175:325&#x2013;358. doi: 10.1016/bs.pmbts.2020.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.pmbts.2020.08.005</ArticleId><ArticleId IdType="pubmed">32958239</ArticleId></ArticleIdList></Reference><Reference><Citation>Biancalana M, Koide S. Molecular Mechanism of Thioflavin-T Binding to Amyloid Fibrils. Biochim Biophys Acta. 2010;1804(7):1405&#x2013;1412. doi: 10.1016/j.bbapap.2010.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbapap.2010.04.001</ArticleId><ArticleId IdType="pmc">PMC2880406</ArticleId><ArticleId IdType="pubmed">20399286</ArticleId></ArticleIdList></Reference><Reference><Citation>Gade Malmos K, Blancas-Mejia LM, Weber B, Buchner J, Ramirez-Alvarado M, Naiki H, Otzen D. ThT 101: a primer on the use of thioflavin T to investigate amyloid formation. Amyloid. 2017;24(1):1&#x2013;16. doi: 10.1080/13506129.2017.1304905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13506129.2017.1304905</ArticleId><ArticleId IdType="pubmed">28393556</ArticleId></ArticleIdList></Reference><Reference><Citation>Villar-Piqu&#xe9; A, Schmitz M, Candelise N, Ventura S, Llorens F, Zerr I. Molecular and Clinical Aspects of Protein Aggregation Assays in Neurodegenerative Diseases. Mol Neurobiol. 2018;55(9):7588&#x2013;7605. doi: 10.1007/s12035-018-0926-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-0926-y</ArticleId><ArticleId IdType="pubmed">29429052</ArticleId></ArticleIdList></Reference><Reference><Citation>Conicella AE, Zerze GH, Mittal J, Fawzi NL. ALS Mutations Disrupt Phase Separation Mediated by &#x3b1;-Helical Structure in the TDP-43 Low-Complexity C-Terminal Domain. Structure. 2016;24(9):1537&#x2013;1549. doi: 10.1016/j.str.2016.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2016.07.007</ArticleId><ArticleId IdType="pmc">PMC5014597</ArticleId><ArticleId IdType="pubmed">27545621</ArticleId></ArticleIdList></Reference><Reference><Citation>Conicella AE, Dignon GL, Zerze GH, Schmidt HB, D'Ordine AM, Kim YC, Rohatgi R, Ayala YM, et al. TDP-43 &#x3b1;-helical structure tunes liquid-liquid phase separation and function. Proc Natl Acad Sci USA. 2020;117(11):5883&#x2013;5894. doi: 10.1073/pnas.1912055117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1912055117</ArticleId><ArticleId IdType="pmc">PMC7084079</ArticleId><ArticleId IdType="pubmed">32132204</ArticleId></ArticleIdList></Reference><Reference><Citation>Wall J, Solomon A. Flow cytometric characterization of amyloid fibrils. Methods Enzymol. 1999;309:460&#x2013;466. doi: 10.1016/S0076-6879(99)09030-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0076-6879(99)09030-8</ArticleId><ArticleId IdType="pubmed">10507040</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguilera P, Mar&#xed;n J, Lagos R, Marcoleta A. Identification of Aggregation-Prone and Gatekeeper Residues in Bacterial Amyloids Using Site-Directed Mutagenesis and Flow Cytometry. Methods Mol Biol. 2022;2538:275&#x2013;284. doi: 10.1007/978-1-0716-2529-3_18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-0716-2529-3_18</ArticleId><ArticleId IdType="pubmed">35951306</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventura S, Navarro S. Screening Protein Aggregation in Cells Using Fluorescent Labels Coupled to Flow Cytometry. Methods Mol Biol. 2019;1873:195&#x2013;212. doi: 10.1007/978-1-4939-8820-4_12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-8820-4_12</ArticleId><ArticleId IdType="pubmed">30341611</ArticleId></ArticleIdList></Reference><Reference><Citation>Porzoor A, Caine JM, Macreadie IG. Pretreatment of chemically-synthesized A&#x3b2;42 affects its biological activity in yeast. Prion. 2014;8(6):404&#x2013;410. doi: 10.4161/19336896.2014.992275.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/19336896.2014.992275</ArticleId><ArticleId IdType="pmc">PMC4601261</ArticleId><ArticleId IdType="pubmed">25495906</ArticleId></ArticleIdList></Reference><Reference><Citation>Espargar&#xf3; A, Sabate R, Ventura S. Thioflavin-S staining coupled to flow cytometr. A screening tool to detect in vivo protein aggregation. Mol Biosyst. 2012;8(11):2839&#x2013;2844. doi: 10.1039/c2mb25214g.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c2mb25214g</ArticleId><ArticleId IdType="pubmed">22868714</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung SY, Keyes C, Duhamel J, Chen P. Concentration Effect on the Aggregation of a Self-Assembling Oligopeptide. Biophys J. 2003;85(1):537&#x2013;548. doi: 10.1016/S0006-3495(03)74498-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-3495(03)74498-1</ArticleId><ArticleId IdType="pmc">PMC1303109</ArticleId><ArticleId IdType="pubmed">12829508</ArticleId></ArticleIdList></Reference><Reference><Citation>Treuheit MJ, Kosky AA, Brems DN. Inverse Relationship of Protein Concentration and Aggregation. Pharm Res. 2002;19(4):511&#x2013;516. doi: 10.1023/A:1015108115452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1015108115452</ArticleId><ArticleId IdType="pubmed">12033388</ArticleId></ArticleIdList></Reference><Reference><Citation>Candelise N, Schmitz M, Th&#xfc;ne K, Cramm M, Rabano A, Zafar S, Stoops E, Vanderstichele H, et al. Effect of the micro-environment on &#x3b1;-synuclein conversion and implication in seeded conversion assays. Transl Neurodegener. 2020;9:5. doi: 10.1186/s40035-019-0181-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-019-0181-9</ArticleId><ArticleId IdType="pmc">PMC6966864</ArticleId><ArticleId IdType="pubmed">31988747</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan AH, Hochschild A. A bacterial global regulator forms a prion. Science. 2017;355(6321):198&#x2013;201. doi: 10.1126/science.aai7776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aai7776</ArticleId><ArticleId IdType="pmc">PMC5460984</ArticleId><ArticleId IdType="pubmed">28082594</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickner RB, Edskes HK, Son M, Bezsonov EE, DeWilde M, Ducatez M. Yeast Prions Compared to Functional Prions and Amyloids. J Mol Biol. 2018;430(20):3707&#x2013;3719. doi: 10.1016/j.jmb.2018.04.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2018.04.022</ArticleId><ArticleId IdType="pubmed">29698650</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakrabortee S, Kayatekin C, Newby GA, Mendillo ML, Lancaster A, Lindquist S. Luminidependens (LD) is an Arabidopsis protein with prion behavior. Proc Ntl Acad Sci USA. 2016;113(21):6065&#x2013;6070. doi: 10.1073/pnas.1604478113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1604478113</ArticleId><ArticleId IdType="pmc">PMC4889399</ArticleId><ArticleId IdType="pubmed">27114519</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan MR, Li L, P&#xe9;rez-S&#xe1;nchez C, Saraf A, Florens L, Slaughter BD, Unruh JR, Si K. Amyloidogenic Oligomerization Transforms Drosophila Orb2 from a Translation Repressor to an Activator. Cell. 2015;163(6):1468&#x2013;1483. doi: 10.1016/j.cell.2015.11.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.11.020</ArticleId><ArticleId IdType="pmc">PMC4674814</ArticleId><ArticleId IdType="pubmed">26638074</ArticleId></ArticleIdList></Reference><Reference><Citation>Si K, Choi YB, White-Grindley E, Majumdar A, Kandel ER. Aplysia CPEB can form prion-like multimers in sensory neurons that contribute to long-term facilitation. Cell. 2010;140(3):421&#x2013;435. doi: 10.1016/j.cell.2010.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.01.008</ArticleId><ArticleId IdType="pubmed">20144764</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogen O, Alessandri-Haber N, Chu C, Gear RW, Levine JD. Generation of a pain memory in the primary afferent nociceptor triggered by PKC&#x3b5; activation of CPEB. J Neurosci. 2012;32(6):2018&#x2013;2026. doi: 10.1523/JNEUROSCI.5138-11.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5138-11.2012</ArticleId><ArticleId IdType="pmc">PMC3305286</ArticleId><ArticleId IdType="pubmed">22323716</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattei V, Martellucci S, Santilli F, Manganelli V, Garofalo T, Candelise N, Caruso A, Sorice M, et al. Morphine Withdrawal Modifies Prion Protein Expression in Rat Hippocampus. PLoS One. 2017;12(1):e0169571. doi: 10.1371/journal.pone.0169571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0169571</ArticleId><ArticleId IdType="pmc">PMC5231345</ArticleId><ArticleId IdType="pubmed">28081197</ArticleId></ArticleIdList></Reference><Reference><Citation>Arendt T, Bullmann T. Neuronal plasticity in hibernation and the proposed role of the microtubule-associated protein tau as a "master switch" regulating synaptic gain in neuronal networks. Am J Physiol Regul Integr Comp Physiol. 2013;305(5):R478&#x2013;489. doi: 10.1152/ajpregu.00117.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpregu.00117.2013</ArticleId><ArticleId IdType="pubmed">23824962</ArticleId></ArticleIdList></Reference><Reference><Citation>Regalado-Reyes M, Benavides-Piccione R, Fernaud-Espinosa I, DeFelipe J, Le&#xf3;n-Espinosa G. Effect of Phosphorylated Tau on Cortical Pyramidal Neuron Morphology during Hibernation. Cereb Cortex Commun. 2020;1(1):tgaa018. doi: 10.1093/texcom/tgaa018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/texcom/tgaa018</ArticleId><ArticleId IdType="pmc">PMC8152943</ArticleId><ArticleId IdType="pubmed">34296096</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattei V, Matarrese P, Garofalo T, Tinari A, Gambardella L, Ciarlo L, Manganelli V, Tasciotti V, et al. Recruitment of cellular prion protein to mitochondrial raft-like microdomains contributes to apoptosis execution. Mol Biol Cell. 2011;22(24):4842&#x2013;4853. doi: 10.1091/mbc.e11-04-0348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e11-04-0348</ArticleId><ArticleId IdType="pmc">PMC3237627</ArticleId><ArticleId IdType="pubmed">22031292</ArticleId></ArticleIdList></Reference><Reference><Citation>Manganelli V, Salvatori I, Costanzo M, Capozzi A, Caissutti D, Caterino M, Valle C, Ferri A, et al. Overexpression of neuroglobin promotes energy metabolism and autophagy induction in human neuroblastoma SH-SY5Y cells. Cells. 2021;10(12):3394&#x2013;3411. doi: 10.3390/cells10123394.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10123394</ArticleId><ArticleId IdType="pmc">PMC8699457</ArticleId><ArticleId IdType="pubmed">34943907</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorice M, Mattei V, Tasciotti V, Manganelli V, Garofalo T, Misasi M. Trafficking of PrPc to mitochondrial raft-like microdomains during cell apoptosis. Prion. 2012;6(4):354&#x2013;358. doi: 10.4161/pri.20479.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/pri.20479</ArticleId><ArticleId IdType="pmc">PMC3609063</ArticleId><ArticleId IdType="pubmed">22842913</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi I, Heaton GR, Lee YK, Yue Z. Regulation of &#x3b1;-synuclein homeostasis and inflammasome activation by microglial autophagy. Sci Adv. 2022;8(43):eabn1298. doi: 10.1126/sciadv.abn1298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abn1298</ArticleId><ArticleId IdType="pmc">PMC9604594</ArticleId><ArticleId IdType="pubmed">36288297</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Ye M, Ma L. The emerging role of autophagy and mitophagy in tauopathies: From pathogenesis to translational implications in Alzheimer's disease. Front Aging Neurosci. 2022;14:1022821. doi: 10.3389/fnagi.2022.1022821.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.1022821</ArticleId><ArticleId IdType="pmc">PMC9618726</ArticleId><ArticleId IdType="pubmed">36325189</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Yokoshi M, Okada H, Kawahara Y. The cleavage pattern of TDP-43 determines its rate of clearance and cytotoxicity. Nat Commun. 2015;6:6183. doi: 10.1038/ncomms7183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7183</ArticleId><ArticleId IdType="pubmed">25630387</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin P, Guo X, Yang W, Yan S, Yang S, Zhao T, Sun Q, Liu Y, et al. Caspase-4 mediates cytoplasmic accumulation of TDP-43 in the primate brains. Acta Neuropathol. 2019;137(6):919&#x2013;937. doi: 10.1007/s00401-019-01979-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01979-0</ArticleId><ArticleId IdType="pmc">PMC6531422</ArticleId><ArticleId IdType="pubmed">30810811</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita T, Hideyama T, Hachiga K, Teramoto S, Takano J, Iwata N, Saido TC, Kwak S. A role for calpain-dependent cleavage of TDP-43 in amyotrophic lateral sclerosis pathology. Nat Commun. 2012;3:1307. doi: 10.1038/ncomms2303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms2303</ArticleId><ArticleId IdType="pubmed">23250437</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang A, Xiang X, Wang J, Lee C, Arakhamia T, Simjanoska M, Wang C, Carlomagno Y, et al. Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases. Cell. 2022;185(8):1346&#x2013;1355. doi: 10.1016/j.cell.2022.02.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.02.026</ArticleId><ArticleId IdType="pmc">PMC9018563</ArticleId><ArticleId IdType="pubmed">35247328</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao F, Robinson JL, Unger T, Posavi M, Amado DA, Elman L, Grossman M, Wolk DA, et al. TMEM106B modifies TDP-43 pathology in human ALS brain and cell-based models of TDP-43 proteinopathy. Acta Neuropathol. 2021;142(4):629&#x2013;642. doi: 10.1007/s00401-021-02330-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-021-02330-2</ArticleId><ArticleId IdType="pmc">PMC8812793</ArticleId><ArticleId IdType="pubmed">34152475</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>